A Double-Blind, Randomized, Single-Dose Study to Assess the Safety and Efficacy of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
Phase of Trial: Phase III
Latest Information Update: 11 Nov 2019
Price : $35 *
At a glance
- Drugs Triamcinolone (Primary) ; Triamcinolone
- Indications Musculoskeletal pain; Osteoarthritis
- Focus Registrational; Therapeutic Use
- Sponsors Flexion Therapeutics
- 11 Nov 2019 Results of a post-hoc analysis presented in a Flexion Therapeutics media release.
- 11 Nov 2019 According to a Flexion Therapeutics media release, post-hoc analysis results were presented at the American College of Rheumatology Annual Meeting 2019.
- 11 Nov 2019 According to a Flexion Therapeutics media release, post-hoc analysis results were presented at the American Association of Hip and Knee Surgeons (AAHKS) Annual Meeting.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History